title: Living related liver transplantation in patients with ABO incompatibility.
authors.affiliation: Second Department of Surgery, Tohoku University, School of Medicine, Sendai, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Takayama
authors.forename: N
authors.initials: N
authors.lastname: Ohkohchi
authors.forename: K
authors.initials: K
authors.lastname: Oikawa
authors.forename: T
authors.initials: T
authors.lastname: Asakura
authors.forename: N
authors.initials: N
authors.lastname: Kawagishi
authors.forename: H
authors.initials: H
authors.lastname: Kikuchi
authors.forename: N
authors.initials: N
authors.lastname: Koyamada
authors.forename: T
authors.initials: T
authors.lastname: Orii
authors.forename: M
authors.initials: M
authors.lastname: Sakurada
authors.forename: H
authors.initials: H
authors.lastname: Doi
authors.forename: K
authors.initials: K
authors.lastname: Fujimori
authors.forename: H
authors.initials: H
authors.lastname: Katoh
authors.forename: M
authors.initials: M
authors.lastname: Satake
authors.forename: S
authors.initials: S
authors.lastname: Satomi
mesh_terms: D000017:ABO Blood-Group System; D001656:Biliary Atresia / Q000601:surgery; D001787:Blood Group Incompatibility; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology*; D019520:Living Donors; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D010290:Parents; D010951:Plasma Exchange; D010956:Plasmapheresis; D016559:Tacrolimus / Q000627:therapeutic use
chemical_list: D000017:ABO Blood-Group System; D006146:Guanidines; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; C037258:gusperimus; D016559:Tacrolimus